Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Feb-24 6:37 PM View:  | Charles River Laboratories ... (CRL) | 15-Feb-24 | Gift | 424 | -- | -- | (< 1%) 48.12K to 47.69K | |
| 31-Jan-24 7:14 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 3,526 | -- | -- | 8% 45.75K to 49.27K | |
| 31-Jan-24 7:14 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 1,159 | $220.28 | $255,305.00 | (2%) 49.27K to 48.12K | |
| 11-Jan-24 4:09 PM View: | Charles River Laboratories ... (CRL) | 10-Jan-24 | Payment of Exercise | 4,590 | $215.19 | $987,722.00 | (9%) 50.37K to 45.77K | |
| 11-Jan-24 4:09 PM View: | Charles River Laboratories ... (CRL) | 10-Jan-24 | Option Exercise | 5,916 | $215.19 | $1,273,060.00 | 13% 44.45K to 50.37K | |
| 21-Nov-23 5:07 PM View: | Charles River Laboratories ... (CRL) | 20-Nov-23 | Purchase | 1,322 | $187.82 | $248,298.00 | 3% 43.13K to 44.45K | |
| 31-May-23 1:24 PM View: | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 216 | $194.12 | $41,929.90 | (< 1%) 43.69K to 43.48K | |
| 31-May-23 1:24 PM View: | Charles River Laboratories ... (CRL) | 28-May-23 | Payment of Exercise | 132 | $194.12 | $25,623.80 | (< 1%) 43.83K to 43.69K | |
| 31-May-23 1:24 PM View: | Charles River Laboratories ... (CRL) | 27-May-23 | Payment of Exercise | 242 | $194.12 | $46,977.00 | (< 1%) 44.07K to 43.83K | |
| 31-May-23 1:24 PM View: | Charles River Laboratories ... (CRL) | 26-May-23 | Grant | 3,812 | -- | -- | 9% 40.26K to 44.07K | |
| 08-Mar-23 4:16 PM View: | Charles River Laboratories ... (CRL) | 07-Mar-23 | Gift | 475 | -- | -- | (1%) 40.73K to 40.26K | |
| 22-Feb-23 4:19 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-23 | Payment of Exercise | 308 | $243.60 | $75,028.80 | (< 1%) 41.04K to 40.73K | |
| 17-Feb-23 5:29 PM View: | Charles River Laboratories ... (CRL) | 16-Feb-23 | Option Exercise | 3,205 | $109.34 | $350,435.00 | 8% 41.04K to 44.24K | |
| 17-Feb-23 5:29 PM View: | Charles River Laboratories ... (CRL) | 16-Feb-23 | Planned Option Sale | 3,205 | $254.39 | $815,310.00 | (7%) 44.24K to 41.04K | |
| 30-Jan-23 4:42 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Grant | 8,435 | -- | -- | 24% 35.76K to 44.19K | |
| 30-Jan-23 4:42 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Payment of Exercise | 3,153 | $244.29 | $770,246.00 | (7%) 44.19K to 41.04K | |
| 31-May-22 6:15 PM View: | Charles River Laboratories ... (CRL) | 29-May-22 | Payment of Exercise | 218 | $244.41 | $53,281.40 | (< 1%) 35.97K to 35.76K | |
| 31-May-22 6:15 PM View: | Charles River Laboratories ... (CRL) | 28-May-22 | Payment of Exercise | 150 | $244.41 | $36,661.50 | (< 1%) 36.12K to 35.97K | |
| 31-May-22 6:15 PM View: | Charles River Laboratories ... (CRL) | 27-May-22 | Grant | 2,455 | -- | -- | 7% 33.67K to 36.12K | |
| 23-Feb-22 4:23 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-22 | Payment of Exercise | 280 | $289.58 | $81,082.40 | (< 1%) 33.95K to 33.67K | |
| 23-Feb-22 4:23 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Payment of Exercise | 274 | $293.61 | $80,449.10 | (< 1%) 34.22K to 33.95K | |
| 01-Feb-22 5:37 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Grant | 11,029 | -- | -- | 41% 27.07K to 38.1K | |
| 01-Feb-22 5:37 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Payment of Exercise | 3,877 | $312.24 | $1,210,550.00 | (10%) 38.1K to 34.22K | |
| 01-Feb-22 5:37 PM View: | Charles River Laboratories ... (CRL) | 23-Sep-21 | Gift | 531 | -- | -- | (2%) 27.6K to 27.07K | |
| 15-Sep-21 11:11 AM View: | Charles River Laboratories ... (CRL) | 14-Sep-21 | Sale (Planned) | 2,344 | $439.90 | $1,031,130.00 | (8%) 29.95K to 27.6K | |
| 15-Sep-21 11:11 AM View: | Charles River Laboratories ... (CRL) | 13-Sep-21 | Private Sale (Planned) | 81 | $442.19 | $35,817.20 | (< 1%) 30.03K to 29.95K | |
| 01-Jun-21 5:58 PM View: | Charles River Laboratories ... (CRL) | 29-May-21 | Payment of Exercise | 216 | $337.99 | $73,005.80 | (< 1%) 30.24K to 30.03K | |
| 01-Jun-21 5:58 PM View: | Charles River Laboratories ... (CRL) | 28-May-21 | Grant | 1,183 | -- | -- | 4% 29.06K to 30.24K | |
| 07-Apr-21 11:26 AM View: | Charles River Laboratories ... (CRL) | 06-Apr-21 | Option Exercise | 18,311 | $113.79 | $2,083,700.00 | 63% 29.06K to 47.37K | |
| 07-Apr-21 11:26 AM View: | Charles River Laboratories ... (CRL) | 06-Apr-21 | Planned Option Sale | 18,311 | $302.61 | $5,541,100.00 | (39%) 47.37K to 29.06K | |
| 07-Apr-21 11:26 AM View: | Charles River Laboratories ... (CRL) | 05-Apr-21 | Option Exercise | 999 | $88.05 | $87,962.00 | 3% 29.06K to 30.06K | |
| 07-Apr-21 11:26 AM View: | Charles River Laboratories ... (CRL) | 05-Apr-21 | Planned Option Sale | 999 | $298.00 | $297,702.00 | (3%) 30.06K to 29.06K | |
| 21-Nov-23 5:07 PM View: | Charles River Laboratories ... (CRL) | 01-Mar-21 | Gift | 350 | -- | -- | (1%) 29.06K to 28.71K | |
| 25-Feb-21 5:22 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-21 | Payment of Exercise | 322 | $282.98 | $91,119.60 | (1%) 29.38K to 29.06K | |
| 23-Feb-21 11:41 AM View: | Charles River Laboratories ... (CRL) | 23-Feb-21 | Payment of Exercise | 315 | $283.59 | $89,330.90 | (1%) 29.7K to 29.38K | |
| 23-Feb-21 11:41 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Payment of Exercise | 308 | $289.55 | $89,181.40 | (1%) 30.0K to 29.7K | |
| 23-Feb-21 11:41 AM View: | Charles River Laboratories ... (CRL) | 19-Feb-21 | Option Exercise | 1,675 | $73.70 | $123,447.00 | 6% 30.0K to 31.68K | |
| 23-Feb-21 11:41 AM View: | Charles River Laboratories ... (CRL) | 19-Feb-21 | Option Sale | 1,675 | $293.92 | $492,311.00 | (5%) 31.68K to 30.0K | |
| 02-Feb-21 11:17 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Grant | 11,862 | -- | -- | 52% 22.85K to 34.71K | |
| 02-Feb-21 11:17 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Payment of Exercise | 4,709 | $260.88 | $1,228,480.00 | (14%) 34.71K to 30.0K | |
| 21-Aug-20 10:48 AM View: | Charles River Laboratories ... (CRL) | 20-Aug-20 | Private Sale | 933 | $213.51 | $199,205.00 | (4%) 23.79K to 22.85K | |
| 02-Jun-20 2:08 PM View: | Charles River Laboratories ... (CRL) | 29-May-20 | Grant | 1,948 | -- | -- | 9% 21.84K to 23.79K | |
| 13-May-20 8:18 AM View: | Charles River Laboratories ... (CRL) | 12-May-20 | Private Sale | 780 | $165.74 | $129,277.00 | (3%) 22.62K to 21.84K | |
| 26-Feb-20 12:26 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-20 | Payment of Exercise | 152 | $162.46 | $24,693.90 | (< 1%) 22.77K to 22.62K | |
| 24-Feb-20 12:38 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-20 | Payment of Exercise | 322 | $173.64 | $55,912.10 | (1%) 23.09K to 22.77K | |
| 24-Feb-20 12:38 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-20 | Payment of Exercise | 315 | $173.64 | $54,696.60 | (1%) 23.41K to 23.09K | |
| 24-Feb-20 12:38 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-20 | Payment of Exercise | 308 | $173.64 | $53,481.10 | (1%) 23.71K to 23.41K | |
| 14-Feb-20 9:43 AM View: | Charles River Laboratories ... (CRL) | 13-Feb-20 | Private Sale | 900 | $172.05 | $154,845.00 | (4%) 24.61K to 23.71K | |
| 10-Feb-20 3:34 PM View: | Charles River Laboratories ... (CRL) | 07-Feb-20 | Grant | 10,745 | -- | -- | 61% 17.71K to 28.46K | |
| 10-Feb-20 3:34 PM View: | Charles River Laboratories ... (CRL) | 07-Feb-20 | Payment of Exercise | 3,846 | $159.07 | $611,783.00 | (14%) 28.46K to 24.61K |